In colorectal cancer cells, SLC2A3 expression is regulated by the TGF-β/JNK/ATF2 signaling pathway, thus, increased SLC2A3 levels exacerbate the aggressiveness of colorectal cancer cells [75]. The gene discussed is MAPK8; the disease is colorectal cancer.